AI summary · may contain errors
VF mutations JAK2V617F and TYK2V678F increase JAK/TYK2 dimer stability, with TYK2V678F showing stronger energetic preference for dimerization in simulations.
- Open access
- 1 cites
Moving in Leukemia, Blood, European Heart Journal, Journal of Clinical Oncology, Arteriosclerosis, Thrombosis, and Vascular Biology, bioRxiv, Journal of Clinical Investigation and medRxiv.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
VF mutations JAK2V617F and TYK2V678F increase JAK/TYK2 dimer stability, with TYK2V678F showing stronger energetic preference for dimerization in simulations.
AI summary · may contain errors
hAB2 CAR-T cells selectively eradicate CALRmut myeloproliferative neoplasm–sustaining stem cells in patient-derived tumor xenografts, eliminating all detectable MPN-propagating function in serial transplantation assays.
AI summary · may contain errors
Overall survival in Waldenström macroglobulinemia did not change across diagnosis eras overall (p=0.64), but improved for patients aged <65 years post-2006 (median 18.8 vs 14.1 years, p=0.018).
AI summary · may contain errors
In CALR-mutant myeloproliferative neoplasms, NK cells show preserved degranulation and high TIGIT expression, with TIGIT blockade reducing platelet numbers in a transplant mouse model.
AI summary · may contain errors
Anti-MPL neutralizing antibody markedly improved cardiac microvascular pathology in chimeric mice with JAK2V617F-mutant blood cells under high-fat/high-cholesterol diet.
AI summary · may contain errors
Calr-Asxl1 co-mutant mice develop more severe thrombocytosis and splenomegaly than Calr single-mutant mice, linked to a stronger megakaryocyte differentiation program.
AI summary · may contain errors
Navitoclax plus ruxolitinib achieved ≥35% spleen volume reduction at week 24 in 63.2% of Janus kinase inhibitor–naïve intermediate-2/high-risk myelofibrosis patients.
AI summary · may contain errors
In phlebotomy-dependent patients with polycythemia vera, rusfertide achieved a clinical response in 77% versus 33% with placebo over weeks 20–32 (P < .0001).
AI summary · may contain errors
Platelet-biased, Vwf-positive hematopoietic stem cells initiate CALR-mutated myeloproliferative neoplasms, with CALRdel52 showing selective Vwf-positive HSC amplification linked to PERK/eIF2a signaling.
AI summary · may contain errors
Fibrocytes make up nearly two-thirds of collagen-producing cells in bone marrow from patients with JAK2V617F-mutated myelofibrosis, exceeding myofibroblasts.
AI summary · may contain errors
In coronary artery bypass graft surgery patients, CHIP in blood (7.9%) is dominated by DNMT3A/TET2/ASXL1, while arterial CHIP-associated mutations show a distinct CALR/SETDB1/PDSS2 profile.
Journals this month
Topics moving, week to 17 Nov 2026
By field